Advancing New Healthcare Solutions Through Collaboration

Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson and William N. Hait, M.D., Ph.D., Global Head of Johnson & Johnson External Innovation, share why academic-industrial partnerships are essential components of the innovation pipeline in their latest Nature Communications article.

Innovators with transformative potential solutions to help or aim to advance precision medicine approaches in autoimmune disease are invited to apply for the chance to receive grant funding from a total of up to $500,000, access to the global JLABS network and mentorship from experts across the Johnson & Johnson Family of Companies.

Connecting with early innovators, entrepreneurs, and scientists to transform great ideas into life-changing solutions for people lies at Johnson & Johnson Innovation’s core. Elena Fernandez-Kleinlein, Regional Head of JLABS EMEA, explains how our global network enables collaboration to tackle some of the world’s most complex health challenges.

Johnson & Johnson Innovation is committed to working with the innovator community around the world with the aim to continue to accelerate potential transformational healthcare solutions during this unprecedented time.